Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:05:28Z
dc.date.available	2017-06-07T07:05:28Z
dc.date.issued	2012
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2465
dc.language.iso	eng
dc.title	Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)
dc.type	Publicación de congreso
dc.authorsophos	Pericay, C
dc.authorsophos	Folprecht, G
dc.authorsophos	Saunders, M
dc.authorsophos	Thomas, A
dc.authorsophos	Roh, J K
dc.authorsophos	Lopez, R
dc.authorsophos	Hohler, T
dc.authorsophos	Kim, J S
dc.authorsophos	Zilocchi, C
dc.authorsophos	Boelle, E
dc.authorsophos	Zalcberg, J
dc.identifier.isi	305826900024
dc.identifier.sophos	8818
dc.issue.number	supp. 4
dc.journal.title	ANNALS OF ONCOLOGY
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	16
dc.page.final	16
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	23

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.